ARTICLE | Company News

Benitec other, infectious news

October 11, 2010 7:00 AM UTC

Benitec said the U.S. Patent and Trademark Office (PTO) Board of Appeals and Interferences reversed all previous obviousness rejection claims related to Benitec's U.S. Patent No. 6,573,099. The '099 patent covers the use of DNA constructs to silence genes by inducing double-stranded RNA in cells. ...